Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...

The CLINITEST Rapid COVID-19 Antigen Self-Test has received FDA EUA for unsupervised self-testing for the SARS-CoV-2 virus by individuals age 14 and older (or adult-collected samples from individuals ...

The potential for IgM cross-reactivity with rheumatoid factor–positive serum samples was observed in blood tests used to detect IgM SARS-CoV-2 by means of gold immunochromatographic and enzyme-linked ...

In a study involving nearly 1,000 patients seen at a Baltimore field hospital during a five-month period in 2022, researchers at Johns Hopkins Medicine, the University of Maryland School of Medicine, ...

In a study involving nearly 1,000 patients seen at the Baltimore Convention Center Field Hospital (BCCFH) during a five-month period in 2022 - researchers at Johns Hopkins Medicine, the University of ...

The COVID-19 pandemic marked the first time in the history of pandemics where self-testing was used as an essential component of a widespread public infection control and prevention strategy. Nearly ...

Add Yahoo as a preferred source to see more of our stories on Google. Covid-19 at home Rapid Test Kit The FDA has extended the shelf life for some COVID-19 tests. Now that allergy season is here, many ...

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

The question quickly arose whether existing rapid antigen tests could detect newly emerging variants. Using clinical samples obtained from diagnostic labs throughout the U.S. from 2020 to 2023, the ...

Adding a throat swab specimen to a nasal specimen significantly increased sensitivity of COVID-19 rapid antigen tests, whether self-collected or collected by a healthcare worker, a randomized clinical ...

The question quickly arose whether existing rapid antigen tests could detect newly emerging variants. Using clinical samples obtained from diagnostic labs throughout the U.S. from 2020 to 2023, the ...